Latest Breaking News On - Trevor burns - Page 3 : vimarsana.com

Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart.

United statesAndrew hamerTrevor burnsHead of research developmentDrug administrationCompany annual report on formCardiol therapeutics incNewsfile corpDesignated newsOrphan drug designationCardiol therapeutic chief medical officerInvestigational new drug applicationUnited states foodCardiol therapeuticsAnnual reportInvestor relations

Cardiol Therapeutics Inc : Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx for Recurrent Pericarditis

Cardiol Therapeutics Inc : Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx for Recurrent Pericarditis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesTrevor burnsAndrew hamerDrug administrationCardiol therapeutics incCompany annual report on formNewsfile corpHead of research developmentDesignated newsOrphan drug designationCardiol therapeutic chief medical officerInvestigational new drug applicationUnited states foodCardiol therapeuticsAnnual reportInvestor relations

Small Towns Strategy document controversy

A SUBMISSION imploring councillors not to pass the Southern Grampians Small Towns Strategy document was made by Glenthompson and District Community Association, vice president, Trevor Burns, at the first Southern Grampians Shire Council (SGSC) ordinary meeting for 2024 on Wednesday night.

Trevor burnsSouthern grampians shire councilDistrict community associationSouthern grampians small towns strategy

Cardiol Therapeutics Inc : Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Cardiol Therapeutics Inc : Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAndrew hamerStefan klotterTrevor burnsCardiol therapeutics incNewsfile corpHead of research developmentCompany annual report on formDrug administrationCompany phaseDesignated newsUnited states foodOrphan drug designationPilot phaseCardiol therapeutic chief medical officerFast track

Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart.

United statesAndrew hamerTrevor burnsCompany phaseCardiol therapeutics incHead of research developmentNewsfile corpCompany annual report on formDrug administrationDesignated newsUnited states foodOrphan drug designationPilot phaseCardiol therapeutic chief medical officerFast trackBreakthrough therapy